Common medication hindering lung cancer treatment

 

https://www.eurekalert.org/news-releases/935917

 

 News Release 24-Nov-2021
Peer-Reviewed Publication
Flinders University

 

A common medication used to treat reflux, heart burn and ulcers could lessen the effectiveness of lung cancer immunotherapy drugs, according to new Flinders University research.

Published in Nature’s British Journal of Cancer, the study investigated the impact of proton pump inhibitors (PPIs) on patients undergoing treatment for non-small-cell lung cancer, the most common type of lung cancer, accounting for 85 percent of cases.

-----